Skip to main content Help with accessibility Skip to main navigation

RHEUMATOID ARTHRITIS: high cost drugs pathway

CCG Approval Status:

Date Added: 20 - Dec - 2018
Body System:
Red

Failure of intensive therapy with a combination of standard DMARDs (usually methotrexate, hydroxychloroquine and sulphasalazine)